this stock isn't going to be around in another 2 years unless there's no buyout and it's a partnership only. I believe things will come hard and fast and this will be all over in the next 6 to 12 months time. they have enough data past and present but don't have the funds or the resources to do full on phase 3 trials for years on end without CR over and over
